A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues
DOI:
https://doi.org/10.4322/acr.2021.322Keywords:
Chondrosarcoma, Extraskeletal Myxoid, Vulva, EWSR1, NR4A3, FISHAbstract
Only 14 cases of extraskeletal myxoid chondrosarcoma (EMC) of the vulva have been documented in the literature. We report a case of a 63-year-old woman with EMC of the vulva confirmed by both EWSR1 and NR4A3 fluorescence in situ hybridization, the latter of which is a more specific probe for this entity. The unusual location of this tumor of prominent myxoid morphology gave rise to a wide differential diagnosis, which necessitated thorough histologic evaluation and confirmatory ancillary testing in the form of immunohistochemistry and cytogenetic studies. This article aims to review extraskeletal myxoid chondrosarcoma of the vulva and various diagnostic clues to help differentiate it from its histologic mimics. This is the fifth case of vulvar EMC in the literature with confirmation of a NR4A3 gene rearrangement.
Downloads
References
O’Neill D, Elghobashy M, Abdelsalam H, Metelko M, El-Ghobashy A. A 5-year follow-up of vulval swelling due to extraskeletal myxoid chondrosarcoma: a rare case report. Mol Clin Oncol. 2019;10(5):483-6. http://dx.doi.org/10.3892/mco.2019.1822. PMid:30967942.
Salah HT, Stivers NS, Jarboe EA, Dodson MK, Ward MB. Extraskeletal myxoid chondrosarcoma of the vulva confirmed by EWSR1 FISH: a case report and review of the literature. Int J Gynecol Pathol. 2020. [Publish ahead of print]. http://dx.doi.org/10.1097/PGP.0000000000000723. PMid:33075019.
Stacchiotti S, Baldi GG, Morosi C, Gronchi A, Maestro R. Extraskeletal myxoid chondrosarcoma: state of the art and current research on biology and clinical management. Cancers. 2020;12(9):2703. http://dx.doi.org/10.3390/cancers12092703. PMid:32967265.
Stacchiotti S, Dagrada GP, Morosi C, et al. Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib. Clin Sarcoma Res. 2012;2(1):22. http://dx.doi.org/10.1186/2045-3329-2-22. PMid:23058004.
Oliveira AM, Sebo TJ, McGrory JE, Gaffey TA, Rock MG, Nascimento AG. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000;13(8):900-8. http://dx.doi.org/10.1038/modpathol.3880161. PMid:10955458.
Horvai AE, Lucas DR, Agaram NP. Extraskeletal myxoid chondrosarcoma. In: Antonescu CR, Blay JY, Bovée JVMG, et al., editors. Soft tissue and bone tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2020. p. 303-5.
Huang H, Chen X, Zheng Z. Extraskeletal myxoid chondrosarcoma: a clinicopathologic analysis of seven cases. Zhonghua Bing Li Xue Za Zhi. 2016;45(1):25-30. PMid:26791550.
Brenca M, Stacchiotti S, Fassetta K, et al. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas. J Pathol. 2019;249(1):90-101. http://dx.doi.org/10.1002/path.5284. PMid:31020999.
Fletcher CDM. Angiomyofibroblastoma. In: Antonescu CR, Blay JY, Bovée JVMG, et al., editors. Soft tissue and bone tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2020. p. 78-9.
Nucci MR, Julia A, Bridge JA. Deep (aggressive) angiomyxoma. In: Antonescu CR, Blay JY, Bovée JVMG, et al., editors. Soft tissue and bone tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2020. p. 266-7.
Huang HY, Mentzel TDW, Shibata T. Myxofibrosarcoma. In: Antonescu CR, Blay JY, Bovée JVMG, et al., editors. Soft tissue and bone tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2020. p. 124-6.
Antonescu CR, Zhang L, Chang NE, et al. EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer. 2010;49(12):1114-24. http://dx.doi.org/10.1002/gcc.20819. PMid:20815032.
Jo VY, Hornick JL, Antonescu CR, Patel RM. Myoepithelioma, myoepithelial carcinoma, and mixed tumour. In: Antonescu CR, Blay JY, Bovée JVMG, et al., editors. Soft tissue and bone tumours. WHO Classification of Tumours. 5th ed. Lyon: IARC; 2020. p. 277-9.
Noguchi H, Mitsuhashi T, Seki K, et al. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes. Hum Pathol. 2010;41(3):336-42. http://dx.doi.org/10.1016/j.humpath.2009.04.028. PMid:19775727.
Flucke U, Tops BB, Verdijk MA, et al. NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma. Virchows Arch. 2012;460(6):621-8. http://dx.doi.org/10.1007/s00428-012-1240-0. PMid:22569967.
Stacchiotti S, Ferrari S, Redondo A, et al. Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2019;20(9):1252-62. http://dx.doi.org/10.1016/S1470-2045(19)30319-5. PMid:31331701.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Autopsy and Case Reports
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
Authors of articles published by Autopsy and Case Report retain the copyright of their work without restrictions, licensing it under the Creative Commons Attribution License - CC-BY, which allows articles to be re-used and re-distributed without restriction, as long as the original work is correctly cited.
